Search Results - "HAAGSMA, E. B"

Inflammatory Bowel Disease After Liver Transplantation: Risk Factors for Recurrence and De Novo Disease by Verdonk, R. C., Dijkstra, G., Haagsma, E. B., Shostrom, V. K., Van den Berg, A. P., Kleibeuker, J. H., Langnas, A. N., Sudan, D. L.

“…Inflammatory bowel disease (IBD) is associated with primary sclerosing cholangitis (PSC) and autoimmune hepatitis (AIH) and can recur or develop de novo after…”
Get full text

Extrahepatic portal vein thrombosis: aetiology and determinants of survival by Janssen, H L A, Wijnhoud, A, Haagsma, E B, van Uum, S H M, van Nieuwkerk, C M J, Adang, R P, Chamuleau, R A F M, van Hattum, J, Vleggaar, F P, Hansen, B E, Rosendaal, F R, van Hoek, B

“…BACKGROUND Malignancy, hypercoagulability, and conditions leading to decreased portal flow have been reported to contribute to the aetiology of extrahepatic…”
Get full text

Inflammatory bowel disease after liver transplantation: the effect of different immunosuppressive regimens by Haagsma, E. B., Van Den Berg, A. P., Kleibeuker, J. H., Slooff, M. J. H., Dijkstra, G.

“…Summary Background : Seemingly conflicting results have been reported on the prevalence and severity of inflammatory bowel disease after liver transplantation…”
Get full text

Symptom experience, nonadherence and quality of life in adult liver transplant recipients by DRENT, G, DE GEEST, S, DOBBELS, F, KLEIBEUKER, J. H, HAAGSMA, E. B

“…Survival outcomes after liver transplantation in adult patients have gradually improved with a five-year survival of about 70% and a ten-year survival of about…”
Get full text

Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study by Janssen, Harry L.A., Meinardi, Johan R., Vleggaar, Frank P., van Uum, Stan H.M., Haagsma, Elizabeth B., van der Meer, Felix J.M., van Hattum, Jan, Chamuleau, Robert A. F.M., Adang, Rob P., Vandenbroucke, Jan P., van Hoek, Bart, Rosendaal, Frits R.

“…In a collaborative multicenter case-control study, we investigated the effect of factor V Leiden mutation, prothrombin gene mutation, and inherited…”
Get full text

Symptom experience associated with immunosuppressive drugs after liver transplantation in adults: possible relationship with medication non-compliance? by Drent, G., Moons, P., De Geest, S., Kleibeuker, J.H., Haagsma, E.B.

“…:  Symptom experience (occurrence and perceived distress) associated with side effects of immunosuppressive medications in organ transplant patients may well…”
Get full text

Liver transplantation : an update by VERDONK, R. C, VAN DEN BERG, A. P, SLOOFP, M. J. H, PORTE, R. J, HAAGSMA, E. B

“…Liver transplantation has been an accepted treatment for end-stage liver disease since the 1980s. Currently it is a highly successful treatment for this…”
Get full text

Liver transplantation for glycogen storage disease types I, III, and IV by Matern, D, Starzl, T E, Arnaout, W, Barnard, J, Bynon, J S, Dhawan, A, Emond, J, Haagsma, E B, Hug, G, Lachaux, A, Smit, G P, Chen, Y T

“…Glycogen storage disease (GSD) types I, III, and IV can be associated with severe liver disease. The possible development of hepatocellular carcinoma and/or…”
Get full text

HCV-related liver cancer in people with haemophilia by MEIJER, K., HAAGSMA, E. B.

“…The topic of this monograph is liver cancer associated with chronic HCV infection. We start with some background information on chronic HCV infection and its…”
Get full text

Surgical treatment of giant haemangioma of the liver by Brouwers, M. A. M., Peeters, P. M. J. G., De Jong, K. P., Haagsma, E. B., Klompmaker, I. J., Bijleveld, C. M. A., Zwaveling, J. H., Slooff, M. J. H.

“…Background The treatment of giant symptomatic haemangioma of the liver is still controversial. This retrospective study reviewed the results of surgical…”
Get full text

Identification of More than One Mutation in the Hepatitis B Virus Polymerase Gene Arising during Prolonged Lamivudine Treatment by Niesters, Hubert G. M., Honkoop, Pieter, Haagsma, Elizabeth B., de Man, Robert A, Schalm, Solko W., Osterhaus, Albert D. M. E.

“…Lamivudine has been shown to be a potent and nontoxic inhibitor of hepatitis B virus (HBV) replication in chronically infected patients. During prolonged…”
Get full text

Bone mineral density in the long term after liver transplantation by HAMBURG, S. M, PIERS, D. A, VAN DEN BERG, A. P, SLOOFF, M. J. H, HAAGSMA, E. B

“…Hepatic osteodystrophy is a complication of chronic liver disease and bone mass is known to decline further in the first year after liver transplantation. The…”
Get full text

Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases by Mulder, A H, Horst, G, Haagsma, E B, Limburg, P C, Kleibeuker, J H, Kallenberg, C G

“…To evaluate the diagnostic significance of neutrophil cytoplasmic antibodies in chronic liver diseases, we assessed the prevalence of neutrophil cytoplasmic…”
Get more information

The Value of Doppler Ultrasound in Cirrhosis and Portal Hypertension by Kok, E. J. van der Jagt, E. B. Haagsma, C. M. A. Bijleveld, P. L. M. Jansen, W. J. Boeve, Th

“…Background: Cirrhosis and portal hypertension affect the flow profile of the liver vasculature. In these conditions Doppler ultrasound can provide important…”
Get full text

A randomized, double‐blind, placebo‐controlled clinical trial of high‐dose interferon‐alpha induction treatment combined with ribavirin for chronic hepatitis C in hemophilia by Meijer, K., Haagsma, E. B., Van Der Meer, J.

Get full text

Antigenemia in the Diagnosis and Monitoring of Active Cytomegalovirus Infection after Liver Transplantation by ptvan den Berg, A. P., Klompmaker, I. J., Haagsma, E. B., Scholten-Sampson, A., Bijleveld, C. M. A., Schirm, J., ptvan der Giessen, M., Slooff, M. J. H., The, T. H.

“…In 45 liver transplant recipients, the value of weekly monitoring of cytomegalovirus (CMV) antigenemia for early diagnosis of active CMV infection was compared…”
Get full text

Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: defined specificities may be associated with distinct clinical features by Roozendaal, C, Van Milligen de Wit, A W, Haagsma, E B, Horst, G, Schwarze, C, Peter, H H, Kleibeuker, J H, Tervaert, J W, Limburg, P C, Kallenberg, C G

“…The clinical significance of antineutrophil cytoplasmic autoantibodies (ANCA) in primary sclerosing cholangitis has not been established. We investigated…”
Get more information

Routine Doppler ultrasound for the detection of clinically unsuspected vascular complications in the early postoperative phase after orthotopic liver transplantation by Kok, T, Slooff, M J, Thijn, C J, Peeters, P M, Verwer, R, Bijleveld, C M, van den Berg, A P, Haagsma, E B, Klompmaker, I J

“…To assess the role of routine Doppler ultrasound in the detection of clinically unsuspected vascular complications in the early postoperative phase after…”
Get more information

Type IIIb glycogen storage disease associated with end‐stage cirrhosis and hepatocellular carcinoma by Haagsma, E B, Smit, G P, Niezen‐Koning, K E, Gouw, A S, Meerman, L, Slooff, M J

“…Type III glycogen storage disease (GSD) is a disorder of carbohydrate metabolism caused by a deficiency of debranching enzyme. Different subtypes with…”
Get full text

Evidence for an increased rate of bacterial infections in liver transplant patients with cytomegalovirus infection by van den Berg, A P, Klompmaker, I J, Haagsma, E B, Peeters, P M, Meerman, L, Verwer, R, The, T H, Slooff, M J

“…It has been reported that cytomegalovirus (CMV) infections increase the susceptibility of transplant patients for other opportunistic infections. Most of these…”
Get more information